X
Access Company Profiles

Get business overview, business operations details specific to this market, products and services, latest developments and more...

Business Email

Select Companies

 

Sweden Pharmaceutical Companies (2024 - 2029)

Numerous companies are making significant strides in the pharmaceutical industry, with several key players leading the charge. These firms are constantly innovating and contributing to the development of new treatments and medicines, which are crucial in combating various diseases and improving global health. These corporations, from large multinational entities to smaller niche businesses, are all integral parts of the healthcare sector. Their collective work and research efforts are instrumental in advancing medical science and providing better healthcare solutions for patients worldwide.

Home Market Analysis Healthcare Research Pharmaceuticals Research Sweden Pharmaceutical Market Companies

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Top Companies in Sweden Pharmaceutical Market

This report lists the top Sweden Pharmaceutical companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Sweden Pharmaceutical industry.

  1. Amgen

  2. Pfizer

  3. Novartis

  4. Orifarm Group

  5. Merck

*Disclaimer: Top companies sorted in no particular order

Sweden Pharmaceutical Market Major Players

Sweden Pharmaceutical Market Concentration

Sweden Pharmaceutical Market Concentration

Sweden Pharmaceutical Company List

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions & Market Definition

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

      1. 4.1.1 Healthcare Expenditure

      2. 4.1.2 Pharmaceutical Imports and Exports

      3. 4.1.3 Epidemiology Data For key Diseases

      4. 4.1.4 Regulatory Landscape/Regulatory Bodies

      5. 4.1.5 Licensing and Market Authorization

      6. 4.1.6 Pipeline Analysis

        1. 4.1.6.1 By Phase

        2. 4.1.6.2 By Sponsor

        3. 4.1.6.3 By Disease

      7. 4.1.7 Statistical Overview

        1. 4.1.7.1 Number of Hospitals

        2. 4.1.7.2 Employment in the Pharmaceutical Sector

        3. 4.1.7.3 R&D Expenditure

      8. 4.1.8 Ease of Doing Business

    2. 4.2 Market Drivers

      1. 4.2.1 Rising Geriatric Population

      2. 4.2.2 Rising Incidence of Chronic Disease

    3. 4.3 Market Restraints

      1. 4.3.1 Stringent Regulatory Scenario

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION (Market Size by Value - USD million)

    1. 5.1 By ATC/Therapeutic Class

      1. 5.1.1 Digestive orgnas and metabolism

      2. 5.1.2 Blood and Blood Forming Organs

      3. 5.1.3 Heart and Circulation

      4. 5.1.4 Skin Preparation

      5. 5.1.5 Urinary and Genital Organs and Sex Hormones

      6. 5.1.6 Systemic Hormonal Preparations, Excluding Sex Hormone and Insulin

      7. 5.1.7 Antiinfectives For Systemic Use

      8. 5.1.8 Tumors and Disorder of Immune System

      9. 5.1.9 Musculo-Skeletal System

      10. 5.1.10 Nervous System

      11. 5.1.11 Antiparasitic Products, Insecticides and Repellents

      12. 5.1.12 Respiratory System

      13. 5.1.13 Sensory Organs

      14. 5.1.14 Others

    2. 5.2 By Drug Type

      1. 5.2.1 Branded

      2. 5.2.2 Generic

    3. 5.3 By Prescription Type

      1. 5.3.1 Prescription Drugs (Rx)

      2. 5.3.2 OTC Drugs

  6. 6. COMPETITIVE LANDSCAPE & COMPANY PROFILES

    1. 6.1 Company Profile

      1. 6.1.1 AbbVie Inc.

      2. 6.1.2 Merck & Co., Inc.

      3. 6.1.3 Amgen Inc.

      4. 6.1.4 Pfizer Inc.

      5. 6.1.5 GlaxoSmithKline plc

      6. 6.1.6 F. Hoffmann-La Roche AG

      7. 6.1.7 AstraZeneca plc

      8. 6.1.8 Eli Lilly and Company

      9. 6.1.9 Novartis International AG

      10. 6.1.10 Sanofi S.A.

      11. 6.1.11 Swedish Orphan Biovitrum AB

      12. 6.1.12 InDex Pharmaceuticals Holding AB

      13. 6.1.13 Medartuum AB

      14. 6.1.14 Life Medical Sweden AB

  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS


Specific to Sweden Pharmaceutical Market
Need More Details On Market Players And Competitors?
Download PDF

Competitive Landscape Report Includes

Company Profiles (includes Global Level Overview, Market Level Overview, Core Business Segments, Financials, Headcount, Key Information, Market Rank, Market Share, Products and Services, and Analysis of Recent Developments). Key Strategic Moves, Market Share Analysis, Company Landscape, and List of Companies.

Sweden Pharmaceutical Market Companies Summary

The pharmaceutical market in Sweden has been significantly impacted by the COVID-19 pandemic, which has led to increased pressure on supply chains and procurement of essential medical supplies. This has resulted in a notable increase in product launches for pharmaceutical drugs, contributing to the growth of the market. The pandemic has also led to an increase in the sale of over-the-counter drugs, particularly for the management of various diseases. Despite the challenges, the pharmaceutical industry in Sweden has experienced significant growth due to the pandemic. The growth of the pharmaceutical market in Sweden is also attributed to the rising geriatric population and the increasing incidence of chronic diseases. The demand for pharmaceutical drugs is higher in the aging population, which is more susceptible to chronic diseases. Additionally, the high burden of chronic and lifestyle disorders within the country is driving the demand for pharmaceutical drugs. On the other hand, the stringent regulatory scenario is a major factor restraining the market growth. Despite these challenges, several companies are making acquisitions and joint ventures to consolidate their positions in the market. Key market players are also engaged in product launches, contributing to the growth of the market.

Explore More

Sweden Pharmaceutical Companies - Table of Contents

  1. 1. COMPETITIVE LANDSCAPE & COMPANY PROFILES

    1. 1.1 Company Profile

      1. 1.1.1 AbbVie Inc.

      2. 1.1.2 Merck & Co., Inc.

      3. 1.1.3 Amgen Inc.

      4. 1.1.4 Pfizer Inc.

      5. 1.1.5 GlaxoSmithKline plc

      6. 1.1.6 F. Hoffmann-La Roche AG

      7. 1.1.7 AstraZeneca plc

      8. 1.1.8 Eli Lilly and Company

      9. 1.1.9 Novartis International AG

      10. 1.1.10 Sanofi S.A.

      11. 1.1.11 Swedish Orphan Biovitrum AB

      12. 1.1.12 InDex Pharmaceuticals Holding AB

      13. 1.1.13 Medartuum AB

      14. 1.1.14 Life Medical Sweden AB

Sweden Pharmaceutical Companies FAQs

Amgen Inc., Pfizer Inc., Novartis International AG, Orifarm Group A/S and Merck & Co., Inc. are the major companies operating in the Sweden Pharmaceutical Market.

Sweden Pharmaceutical Market Report Snapshots

Sweden Pharmaceutical Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)